Biogen, Eisai Get FDA Nod for Leqembi IV Maintenance Dosing
Biogen and Eisai have won Food and Drug Administration approval of an intravenous maintenance dosing of their Leqembi drug for early Alzheimer's disease. The companies late Sunday said the FDA approved the maintenance dosing of once every four weeks after 18 months of the initiation phase of once every two weeks.
Discover what FDA's red dye ban means for your food safety. Learn which synthetic colors remain in your favorite foods and ...
1don MSN
The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...
An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.
Over 35 years after the first study linking the artificial food dye Red 3 to thyroid cancer in rats was published, the U.S.
In 2024, food recalls in the US seemed to soar. Between headline-making outbreaks of listeria and E. coli and problems with ...
The FDA announced the changes in a “ prevention strategy ” to keep fresh and frozen berries from being contaminated with ...
The Trump administration has put a freeze on many federal health agency communications with the public through at least the ...
Hosted on MSN8h
Montana bill seeks state panel on food safetyResearch shows toxic additives have been overlooked in the U.S. food supply, though the federal Food and Drug Administration ...
Dr. Dorothy Fink, the acting secretary for the Department of Health and Human Services under President Donald Trump, has ...
The Trump administration has put a freeze on many federal health agency communications with the public through at least the ...
The U.S. Food and Drug Administration is raising alarms about Librela, warning veterinarians of potential adverse effects, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback